Journal of Organic Chemistry 2009-11-20

Solution structure of succinylacetone, an unsymmetrical beta-diketone, as studied by 13C NMR and GIAO-DFT calculations.

Dominika Bal, Anna Kraska-Dziadecka, Adam Gryff-Keller

Index: J. Org. Chem. 74(22) , 8604-9, (2009)

Full Text: HTML

Abstract

The enolization degrees of succinylacetone, an important heme biosynthesis inhibitor, have been determined in CDCl(3) and water solutions using (1)H NMR. The solution structures of SA have been investigated using a combined NMR/theoretical [GIAO DFT PBE1PBE/6-311++G(2d, p) PCM] approach. The populations of both enolic forms undergoing enol-enol equilibriums for SA and a series of unsymmetrical beta-diketones have been established by a quantitative comparison of the experimental (13)C NMR chemical shifts and calculated shielding constants. Moreover, using the same method and considering various trial structures differing in conformation and/or hydration of neutral SA molecule as well as its monoanion and dianion the structures of the most abundant species being present in the investigated water solutions have been deduced.

Related Compounds

  • 4,6-Dioxoheptanoic...

Related Articles:

The heme exporter Flvcr1 regulates expansion and differentiation of committed erythroid progenitors by controlling intracellular heme accumulation.

2015-06-01

[Haematologica 100 , 720-9, (2015)]

Heme Oxygenase-1 Regulation of Matrix Metalloproteinase-1 Expression Underlies Distinct Disease Profiles in Tuberculosis.

2015-09-15

[J. Immunol. 195 , 2763-73, (2015)]

Single dose NTBC-treatment of hereditary tyrosinemia type I.

2012-09-01

[J. Inherit. Metab. Dis. 35(5) , 831-6, (2012)]

LC-MS/MS method for simultaneous determination on a dried blood spot of multiple analytes relevant for treatment monitoring in patients with tyrosinemia type I.

2012-01-17

[Anal. Chem. 84(2) , 1184-8, (2012)]

Clinical, biochemical, and genetic analysis of a Korean neonate with hereditary tyrosinemia type 1.

2009-01-01

[Clin. Chem. Lab Med. 47(8) , 930-3, (2009)]

More Articles...